BEVACIZUMAB AND PLATINUM-BASED CHEMOTHERAPY IN RELAPSED OVARIAN CANCER TREATMENT

被引：0
|
作者：
Davidenko, I. [1 ]
Kazantseva, M. [1 ]
Porhanova, N. [1 ]
Potemin, S. [1 ]
Oganyan, M. [1 ]
Syrota, L. [1 ]
Shmatkova, V. [1 ]
机构：
[1] Reg Oncol Ctr, Krasnodar, Russia
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2013年 / 23卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] 2ND LINE CHEMOTHERAPY IN OVARIAN-CANCER AFTER FAILURE OF PLATINUM-BASED FRONT TREATMENT
    BRUZZONE, M
    CHIARA, S
    CONTE, PF
    ROSSO, R
    GIACCONE, G
    CARNINO, F
    PASETTO, G
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1986, 5 (01) : 79 - 83
  • [42] Comparative effectiveness of platinum-based chemotherapy versus taxane and other regimens for ovarian cancer
    Xianglin L. Du
    Rohan C. Parikh
    David R. Lairson
    Sharon H. Giordano
    Putao Cen
    Medical Oncology, 2013, 30
  • [43] Platinum-based adjuvant chemotherapy for early-stage epithelial ovarian cancer: Single or combination chemotherapy?
    Adams, G.
    Zekri, J. M.
    Wong, H.
    Green, J. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [44] SOX18 Expression Predicts Response to Platinum-based Chemotherapy in Ovarian Cancer
    Pula, Bartosz
    Kobierzycki, Christopher
    Solinski, Daniel
    Olbromski, Matuesz
    Nowak-Markwitz, Ewa
    Spaczynski, Marek
    Kedzia, Witold
    Zabel, Maciej
    Dziegiel, Piotr
    ANTICANCER RESEARCH, 2014, 34 (08) : 4029 - 4037
  • [45] Effects of PARP Inhibitors on Subsequent Platinum-Based Chemotherapy in Patients with Recurrent Ovarian Cancer
    Kokabu, Tetsuya
    Tarumi, Yosuke
    Aoki, Kota
    Okamura, Ayaka
    Aoyama, Kohei
    Kataoka, Hisashi
    Yoriki, Kaori
    Mori, Taisuke
    CANCERS, 2024, 16 (15)
  • [46] Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer
    Marchini, Sergio
    Fruscio, Robert
    Clivio, Luca
    Beltrame, Luca
    Porcu, Luca
    Nerini, Ilaria Fuso
    Cavalieri, Duccio
    Chiorino, Giovanna
    Cattoretti, Giorgio
    Mangioni, Costantino
    Milani, Rodolfo
    Torri, Valter
    Romualdi, Chiara
    Zambelli, Alberto
    Romano, Michela
    Signorelli, Mauro
    di Giandomenico, Silvana
    D'Incalci, Maurizio
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (02) : 520 - 530
  • [47] Is platinum-based chemotherapy with paclitaxel effective in optimally debulked patients with advanced ovarian cancer?
    Roovers, JPWR
    Sijmons, EA
    van Leeuwen, JHS
    Mol, BWJ
    Witteveen, PO
    Slee, PHTJ
    Heintz, APM
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2001, 97 (01): : 80 - 84
  • [48] Related Clinical Factors of Platinum-Based Chemotherapy Resistance in Patients with Epithelial Ovarian Cancer
    Xiong, Zhuo
    Ha, Chunfang
    Li, Ruyue
    Wu, Mingyong
    Wei, Meng
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2024, 89 (06) : 469 - 477
  • [49] PROGNOSTIC FACTORS FOR PLATINUM-BASED COMBINATION CHEMOTHERAPY OF ADVANCED OVARIAN-CANCER (ADOVCA)
    VOGL, SE
    KAPLAN, BH
    GREENWALD, E
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 429 - 429
  • [50] ADAMTS16 mutations sensitize ovarian cancer cells to platinum-based chemotherapy
    Yasukawa, Maya
    Liu, Yuexin
    Hu, Limei
    Cogdell, David
    Gharpure, Kshipra M.
    Pradeep, Sunila
    Nagaraja, Archana S.
    Sood, Anil K.
    Zhang, Wei
    ONCOTARGET, 2017, 8 (51) : 88410 - 88420
12345